Results 141 to 150 of about 533,242 (221)

Immunologic desensitization to nilotinib in a patient with chronic myeloid leukemia with hypersensitivity and complex comorbidities. [PDF]

J Allergy Clin Immunol Glob
Widagdo TSC, Fetarayani D, Nurani WK, Baskoro A, Soegiarto G.   +4 more
europepmc   +1 more source

Hilar and Mediastinal Lymphadenopathy as a Potential Manifestation of Azathioprine-Associated Hypersensitivity Syndrome. [PDF]

Pharmaceuticals (Basel)
Ziaka M.
europepmc   +1 more source

Perioperative Management of Coexisting Mast Cell Activation Syndrome and Malignant Hyperthermia Susceptibility: A Case Report and Novel Approach to Local Analgesia. [PDF]

Case Rep Anesthesiol
Gearing PF, Nack T, Liyanage D, Martis WR, Findlay M.   +4 more
europepmc   +1 more source

Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review. [PDF]

An Bras Dermatol
El-Amawy HS.
europepmc   +1 more source

HORMONE RESISTANCE AND HYPERSENSITIVITY: CLINICAL STUDY OF CORTISOL RESISTANCE AND HYPERSENSITIVITY AND INSULIN HYPERSENSITIVITY

Japanese Journal of National Medical Services, 2003
IIDA, Sayomi, FUJII, Hiroshi, IKEDA, Hirokazu   +2 more
openaire   +1 more source

Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus. [PDF]

Diabetes Obes Metab
Wang Y, Wang S, Wang W, Li X, Leohr J, Pires V, Katz ML, Child CJ, Konrad RJ.   +8 more
europepmc   +1 more source

Allopurinol-associated Drug Reaction with Eosinophilia and Systemic Symptom Syndrome: A Severe Delayed Drug Hypersensitivity Reaction. [PDF]

Ann Afr Med
Mahato SK, Sudha TYS, Kumar S, Babu R, Kumar V.   +4 more
europepmc   +1 more source

New Insights Into Immunomodulatory Strategies for Drug Hypersensitivity Reactions: An EAACI Task Force Report. [PDF]

Clin Transl Allergy
Copaescu AM, Gueli V, Chahuan J, Albalawi W, Sfriso G, Giovannini M, de Las Vecillas L, Karavelia A, Labella M, Fernandez-Santamaria R, Mori F, Garvey LH, Bonadonna P, Torres MJ.   +13 more
europepmc   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design. [PDF]

Diabetes Obes Metab
Cherkas A, Rotthaeuser B, Porksen N, Labard P, Nguyên-Pascal ML, Coudert M, Berthou B, Baccara-Dinet M, Boka G, Peakman M, Reschke F, Haller MJ.   +11 more
europepmc   +1 more source

Secondary Adrenal Insufficiency and Multisystem Endocrinopathy Following Immune Checkpoint Inhibitor Therapy. [PDF]

Ann Afr Med
Fedorova O, AlSaraj F.
europepmc   +1 more source